Autoimmune hepatitis associated with bile duct injury resembling chronic non-suppurative destructive cholangitis
- PMID: 12167107
- DOI: 10.1046/j.1440-1827.2002.01377.x
Autoimmune hepatitis associated with bile duct injury resembling chronic non-suppurative destructive cholangitis
Abstract
Autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC) are representative autoimmune liver diseases in which hepatocytes and intrahepatic bile ducts, respectively, are selectively damaged by autoimmune mechanisms. Bile duct injury and loss is characteristic of PBC and chronic non-suppurative destructive cholangitis (CNSDC), in particular, is a histological hallmark of PBC. In this report, we present an unusual case of AIH accompanied by CNSDC-like bile duct injury in a 46-year-old woman. The patient's serum aminotransferase level was abnormally high. The serum levels of alkaline phosphatase, gamma-GTP and IgG were also elevated, but the IgM level was within normal limits. The titer of antismooth muscle antibody (SMA) was 1:80, while antinuclear autoantibody (ANA) and the M2 fraction of antimitochondrial antibody (AMA) were both negative. Liver biopsy disclosed CNSDC-like bile duct injuries and severe interface hepatitis and lobular hepatitis with perivenular zonal necrosis were observed. The aggregate score of the International Autoimmune Hepatitis Group corresponded to the category of probable AIH. Immunohistochemically, histocompatibility leukocyte antigen-DR, which is aberrantly expressed in the damaged bile ducts of PBC, was not found in the injured bile ducts of this case. Laboratory data were much improved by treatment with prednisone, but ursodeoxycholic acid was not effective. Although the possibility of an overlapping syndrome of AIH- and AMA-negative PBC could not be excluded, this case was diagnosed as AIH with CNSDC-like bile duct lesions.
Similar articles
-
Are bile duct lesions of primary biliary cirrhosis distinguishable from those of autoimmune hepatitis and chronic viral hepatitis? Interobserver histological agreement on trimmed bile ducts.J Gastroenterol. 2005 Feb;40(2):164-70. doi: 10.1007/s00535-004-1514-7. J Gastroenterol. 2005. PMID: 15770400
-
Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.Minerva Gastroenterol Dietol. 2009 Mar;55(1):53-70. Minerva Gastroenterol Dietol. 2009. PMID: 19212308 Review.
-
Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.Hepatology. 2002 Feb;35(2):409-13. doi: 10.1053/jhep.2002.30902. Hepatology. 2002. PMID: 11826416 Clinical Trial.
-
cDNA microarray analysis of autoimmune hepatitis, primary biliary cirrhosis and consecutive disease manifestation.J Autoimmun. 2005 Sep;25(2):133-40. doi: 10.1016/j.jaut.2005.03.009. Epub 2005 Sep 16. J Autoimmun. 2005. PMID: 16150573
-
[Autoimmune liver diseases and their overlap syndromes].Praxis (Bern 1994). 2006 Sep 6;95(36):1363-81. doi: 10.1024/1661-8157.95.36.1363. Praxis (Bern 1994). 2006. PMID: 16989180 Review. German.
Cited by
-
Molecular mechanisms of cholangiopathy in primary biliary cirrhosis.Med Mol Morphol. 2006 Jun;39(2):55-61. doi: 10.1007/s00795-006-0321-z. Med Mol Morphol. 2006. PMID: 16821141 Review.
-
Vitamin D supplementation for autoimmune hepatitis: A need for further investigation.World J Hepatol. 2022 Jan 27;14(1):295-299. doi: 10.4254/wjh.v14.i1.295. World J Hepatol. 2022. PMID: 35126856 Free PMC article.
-
Overlap syndromes: an emerging diagnostic and therapeutic challenge.Saudi J Gastroenterol. 2014 Nov-Dec;20(6):342-9. doi: 10.4103/1319-3767.145316. Saudi J Gastroenterol. 2014. PMID: 25434314 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical